Combigene (Sweden) Market Value
| COMBI Stock | SEK 2.22 0.06 2.63% |
| Symbol | Combigene |
Combigene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Combigene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Combigene.
| 12/10/2024 |
| 01/09/2025 |
If you would invest 0.00 in Combigene on December 10, 2024 and sell it all today you would earn a total of 0.00 from holding Combigene AB or generate 0.0% return on investment in Combigene over 30 days. Combigene is related to or competes with Kancera AB, BioInvent International, Oncopeptides, and Acarix AS. CombiGene AB engages in the development and commercialization of gene therapy for the treatment of neurological and psyc... More
Combigene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Combigene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Combigene AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.88 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 51.27 | |||
| Value At Risk | (9.77) | |||
| Potential Upside | 9.02 |
Combigene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Combigene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Combigene's standard deviation. In reality, there are many statistical measures that can use Combigene historical prices to predict the future Combigene's volatility.| Risk Adjusted Performance | 0.0098 | |||
| Jensen Alpha | 0.0165 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.002 |
Combigene AB Backtested Returns
Currently, Combigene AB is extremely dangerous. Combigene AB secures Sharpe Ratio (or Efficiency) of 9.0E-4, which signifies that the company had a 9.0E-4% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Combigene AB, which you can use to evaluate the volatility of the firm. Please confirm Combigene's Downside Deviation of 6.88, risk adjusted performance of 0.0098, and Mean Deviation of 5.02 to double-check if the risk estimate we provide is consistent with the expected return of 0.0078%. The firm shows a Beta (market volatility) of -1.06, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Combigene are expected to decrease slowly. On the other hand, during market turmoil, Combigene is expected to outperform it slightly. Combigene AB right now shows a risk of 8.26%. Please confirm Combigene AB jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to decide if Combigene AB will be following its price patterns.
Auto-correlation | -0.37 |
Poor reverse predictability
Combigene AB has poor reverse predictability. Overlapping area represents the amount of predictability between Combigene time series from 10th of December 2024 to 25th of December 2024 and 25th of December 2024 to 9th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Combigene AB price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Combigene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Combigene AB lagged returns against current returns
Autocorrelation, which is Combigene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Combigene's stock expected returns. We can calculate the autocorrelation of Combigene returns to help us make a trade decision. For example, suppose you find that Combigene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Combigene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Combigene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Combigene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Combigene stock over time.
Current vs Lagged Prices |
| Timeline |
Combigene Lagged Returns
When evaluating Combigene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Combigene stock have on its future price. Combigene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Combigene autocorrelation shows the relationship between Combigene stock current value and its past values and can show if there is a momentum factor associated with investing in Combigene AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Combigene Stock Analysis
When running Combigene's price analysis, check to measure Combigene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Combigene is operating at the current time. Most of Combigene's value examination focuses on studying past and present price action to predict the probability of Combigene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Combigene's price. Additionally, you may evaluate how the addition of Combigene to your portfolios can decrease your overall portfolio volatility.